Search Result "Residual cardiovascular risk."
Cholesterol Lowering Therapy: Treat to Target or Reduce the Global Risk? The Unresolved Problem of Residual Risk
Journal: Current Pharmaceutical Design
Volume: 22 Issue: 37 Year: 2016 Page: 5676-5686
Author(s): Giulia Bruzzone,Giorgia Corbelli,Paola Belci,Annalaura Cremonini,Aldo Pende,Livia Pisciotta
Vascular Remodelling in Well-controlled Hypertensive Patients: The Challenge of Residual Risk Management
Journal: Current Pharmaceutical Design
Volume: 23 Issue: 10 Year: 2017 Page: 1445-1452
Author(s): Massimo Puato,Chiara Nardin,Marta Zanon,Paolo Palatini,Paolo Pauletto,Marcello Rattazzi
Confronting the Residual Cardiovascular Risk Beyond Statins: The Role of Fibrates, Omega-3 Fatty Acids, or Niacin, in Diabetic Patients
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 22 Year: 2014 Page: 3675-3688
Author(s): Georgios A. Christou,Evangelos C. Rizos,Aris Mpechlioulis,Carlo Penzo,Andrea Pacchioni,Dimitrios N. Nikas
Roles of Cardiovascular Risk Factors in Endothelial Nitric Oxide Synthase Regulation: An Update
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 22 Year: 2014 Page: 3563-3578
Author(s): Md Saha Jamaluddin,Zhengdong Liang,Jian-Ming Lu,Qizhi Yao,Changyi Chen
Rheumatoid Arthritis and Cardiovascular Risk: Between Lights and Shadows
Journal: Current Rheumatology Reviews
Volume: 9 Issue: 2 Year: 2013 Page: 100-104
Author(s): Vincenzo Bruzzese, Cesare Hassan, Lorenzo Ridola, Angelo Zullo
Assessment of Lifetime Risk for Cardiovascular Disease: Time to MoveForward
Journal: Current Cardiology Reviews
Volume: 20 Issue: 6 Year: 2024 Page: 18-33
Author(s): Evangelia G. Sigala,Demosthenes B. Panagiotakos
Biomarkers Determining Cardiovascular Risk in Patients with Kidney Disease
Journal: Current Medicinal Chemistry
Volume: 19 Issue: 16 Year: 2012 Page: 2555-2571
Author(s): G. Siasos,D. Tousoulis,S. Michalea,E. Oikonomou,C. Kolia,S. Kioufis,A. Synetos,K. Vlasis,A. G. Papavassiliou,C. Stefanadis
Lipoprotein (a) and Cardiovascular Risk: The Show Must go on
Journal: Current Medicinal Chemistry
Volume: 24 Issue: 10 Year: 2017 Page: 989-1006
Author(s): Niki Katsiki,Khalid Al-Rasadi,Dimitri P. Mikhailidis
Management of Cardiovascular Risk Factors in Patients with Metabolic Syndrome
Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 5 Issue: 3 Year: 2007 Page: 209-214
Author(s): Alejandro de la Sierra, Luis Miguel Ruilope
Mechanisms Underlying the Cardiovascular Effects of COX-Inhibition: Benefits and Risks
Journal: Current Pharmaceutical Design
Volume: 13 Issue: 2 Year: 2007 Page: 2215-2227
Author(s): Jose Martinez-Gonzalez, Lina Badimon